Mostrar el registro sencillo del ítem
dc.contributor.author | Alonso, J. | |
dc.contributor.author | Liu, Z. | |
dc.contributor.author | Evans-Lacko, S. | |
dc.contributor.author | Sadikova, E. | |
dc.contributor.author | Sampson, N. | |
dc.contributor.author | Chatterji, S. | |
dc.contributor.author | Abdulmalik, J. | |
dc.contributor.author | Aguilar-Gaxiola, S. | |
dc.contributor.author | Al-Hamzawi, A. | |
dc.contributor.author | Andrade, L.H. | |
dc.contributor.author | Bruffaerts, R. | |
dc.contributor.author | Cardoso, G. | |
dc.contributor.author | Cia, A. | |
dc.contributor.author | Florescu, S. | |
dc.contributor.author | de Girolamo, G. | |
dc.contributor.author | Gureje, O. | |
dc.contributor.author | Haro, J.M. | |
dc.contributor.author | He, Y. | |
dc.contributor.author | de Jonge, P. | |
dc.contributor.author | Karam, E.G. | |
dc.contributor.author | Kawakami, N. | |
dc.contributor.author | Kovess-Masfety, V. | |
dc.contributor.author | Lee, S. | |
dc.contributor.author | Levinson, D. | |
dc.contributor.author | Medina-Mora, M.E. | |
dc.contributor.author | Navarro-Mateu, F. | |
dc.contributor.author | Pennell, B.E. | |
dc.contributor.author | Piazza Ferrand, Marina Julia | |
dc.contributor.author | Posada-Villa, J. | |
dc.contributor.author | ten Have, M. | |
dc.contributor.author | Zarkov, Z. | |
dc.contributor.author | Kessler, R.C. | |
dc.contributor.author | Thornicroft, G. | |
dc.contributor.author | WHO World Mental Health Survey | |
dc.date.accessioned | 2019-04-24T18:23:52Z | |
dc.date.available | 2019-04-24T18:23:52Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/6465 | |
dc.description.abstract | Background: Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12-month DSM-IV (where DSM is Diagnostic Statistical Manual) anxiety disorder in 21 countries, the proportion who (i) perceived a need for treatment; (ii) received any treatment; and (iii) received possibly adequate treatment. Methods: Data from 23 community surveys in 21 countries of the World Mental Health (WMH) surveys. DSM-IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM-IV included posttraumatic stress disorder among anxiety disorders, while it is not considered so in the DSM-5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or nonmedical professional) for “problems with emotions, nerves, mental health, or use of alcohol or drugs.” Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, complementary alternative medicine or nonmedical care (8+ visits). Results: Of 51,547 respondents (response = 71.3%), 9.8% had a 12-month DSM-IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. Of those with 12-month anxiety only 41.3% perceived a need for care. Lower treatment levels were found for lower income countries. Conclusions: Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment. | en_US |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.relation.ispartofseries | Depression and Anxiety | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | alcohol consumption | en_US |
dc.subject | alternative medicine | en_US |
dc.subject | anxiety disorder | en_US |
dc.subject | Argentina | en_US |
dc.subject | Article | en_US |
dc.subject | Belgium | en_US |
dc.subject | Brazil | en_US |
dc.subject | Bulgaria | en_US |
dc.subject | China | en_US |
dc.subject | Colombia | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug use | en_US |
dc.subject | DSM-5 | en_US |
dc.subject | DSM-IV | en_US |
dc.subject | emotion | en_US |
dc.subject | France | en_US |
dc.subject | Germany | en_US |
dc.subject | health survey | en_US |
dc.subject | human | en_US |
dc.subject | Iraq | en_US |
dc.subject | Israel | en_US |
dc.subject | Italy | en_US |
dc.subject | Japan | en_US |
dc.subject | Lebanon | en_US |
dc.subject | mental health care | en_US |
dc.subject | Mexico | en_US |
dc.subject | Netherlands | en_US |
dc.subject | Nigeria | en_US |
dc.subject | Peru | en_US |
dc.subject | Portugal | en_US |
dc.subject | practice guideline | en_US |
dc.subject | priority journal | en_US |
dc.subject | psychotherapy | en_US |
dc.subject | Romania | en_US |
dc.subject | Spain | en_US |
dc.subject | United States | en_US |
dc.subject | adolescent | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | anxiety disorder | en_US |
dc.subject | female | en_US |
dc.subject | global health | en_US |
dc.subject | health care quality | en_US |
dc.subject | health care survey | en_US |
dc.subject | male | en_US |
dc.subject | mental health | en_US |
dc.subject | middle aged | en_US |
dc.subject | patient attitude | en_US |
dc.subject | statistics and numerical data | en_US |
dc.subject | very elderly | en_US |
dc.subject | young adult | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Adult | en_US |
dc.subject | Aged | en_US |
dc.subject | Aged, 80 and over | en_US |
dc.subject | Anxiety Disorders | en_US |
dc.subject | Female | en_US |
dc.subject | Global Health | en_US |
dc.subject | Health Care Surveys | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Mental Health | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Patient Acceptance of Health Care | en_US |
dc.subject | Quality of Health Care | en_US |
dc.subject | Young Adult | en_US |
dc.title | Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1002/da.22711 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.24 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#5.01.00 | |
dc.relation.issn | 1520-6394 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |